-
公开(公告)号:US11795218B2
公开(公告)日:2023-10-24
申请号:US16795468
申请日:2020-02-19
申请人: BioNTech AG , Ganymed Pharmaceuticals GmbH , TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
发明人: Ugur Sahin , Ozlem Tureci , Korden Walter , Meike Wagner , Maria Kreuzberg , Sabine Hacker , Stefan Jacobs
IPC分类号: C07K16/28 , A61K39/395 , A61K31/337 , A61K31/5365 , A61K31/7048 , A61K31/7064 , A61K33/243 , C07K16/30 , A61K47/68 , G01N33/574 , A61N5/10 , A61K39/00
CPC分类号: C07K16/28 , A61K31/337 , A61K31/5365 , A61K31/7048 , A61K31/7064 , A61K33/243 , A61K39/39558 , A61K47/6851 , A61N5/10 , C07K16/30 , G01N33/57484 , G01N33/57492 , A61K2039/505 , C07K2317/56 , C07K2317/73 , C07K2317/732 , C07K2317/76 , G01N2333/705 , G01N2800/52
摘要: The present invention provides methods for diagnosis or treatment of cancer diseases involving cancer stem cells comprising targeting CLDN6. In particular, the present invention provides a method of determining cancer stem cells comprising detecting cells expressing CLDN6. Furthermore, the present invention provides a method of treating or preventing cancer comprising inhibiting and/or eliminating cancer stem cells by administering an antibody having the ability of binding to CLDN6 to a cancer patient.
-
公开(公告)号:US10724103B2
公开(公告)日:2020-07-28
申请号:US15675148
申请日:2017-08-11
申请人: BioNTech AG
发明人: Ozlem Tureci , Ugur Sahin , Sandra Schneider , Gerd Helftenbein , Volker Schluter , Dirk Usener , Philippe Thiel , Michael Koslowski
IPC分类号: C12Q1/686 , C12Q1/6886 , C07K14/47 , A61K39/395 , A61K45/06 , C07K16/28 , C07K16/30 , G01N33/53
摘要: The invention relates to the identification of gene products that are the result of tumor-associated expression and the nucleic acids encoding the same. The invention also relates to the therapy and diagnosis of diseases wherein these gene products are the result of an aberrant tumor-associated expression. The invention also relates to the proteins, polypeptides and peptides that are the result of tumor-associated expression and to the nucleic acids encoding the same.
-
公开(公告)号:US10428149B2
公开(公告)日:2019-10-01
申请号:US15558372
申请日:2016-03-18
申请人: UNIVERSITÄT STUTTGART , BIONTECH AG
发明人: Ugur Sahin , Roland Kontermann , Klaus Pfizenmaier , Martin Siegemund , Meike Hutt , Oliver Seifert
IPC分类号: C07K16/32 , C07K16/28 , C07K14/705
摘要: The present invention relates to a polypeptide comprising a component A with at least three tumor necrosis factor (TNF) homology domains of TNF-ligand family members (THD) in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof, and a component B comprising a dimerization domain. Further, the present invention relates to a polypeptide comprising at least three THDs in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof. Further, the invention relates to a nucleic acid comprising said polypeptides, a vector comprising said nucleic acid and a pharmaceutical composition comprising said polypeptides, or said nucleic acids or said vector. Further, the present invention relates to said polypeptides, said nucleic acid or said vector for the use as a medicament or for the use in the diagnosis, prophylaxis or treatment of hyperproliferative disorders and inflammatory disorders.
-
公开(公告)号:US10302647B2
公开(公告)日:2019-05-28
申请号:US14887979
申请日:2016-03-07
申请人: BioNTech AG
发明人: Ugur Sahin , Ozlem Tureci , Michael Koslowski , Gerd Helftenbein , Dirk Usener , Volker Schluter
IPC分类号: C12Q1/686 , G01N33/574 , C12Q1/6886 , G06F19/22
摘要: The invention relates to identifying tumor-associated genetic products and encoding nucleic acids thereof. A therapy and diagnosis of diseases in which the tumor-associated genetic products are aberrantly expressed, proteins, polypeptides and peptides which are expressed in association with tumor and the encoding nucleic acids for said proteins, polypeptides and peptides are also disclosed.
-
公开(公告)号:US20190070248A1
公开(公告)日:2019-03-07
申请号:US15741902
申请日:2015-07-14
申请人: Biontech AG , Tron-Translationale Onkologie An Der Johannes Gutebert-Universital Mainz GGMBH , JPT Peptides Technologies GMBH
发明人: Ugur Sahin , Laura Marie Kring , Markus Fiedler , Matin Daneschdar , Hans-Ulrich Schmoldt , Ulf Reimer , Karsten Schnatbaum
摘要: The present invention provides molecules that mimic antigenic determinants of the CD3 (cluster of differentiation 3) T-cell co-receptor epsilon chain (CD3ε). These molecules compete with CD3ε for binding to a CD3ε binding domain. e.g. a CD3ε binding domain of an antibody, and are capable of detecting antibodies against CD3ε. The mimotopes of the invention may be used to generate or inhibit immune responses in animals and preferably humans. Additionally, they may serve as tools for anti-CD3ε antibody purification and the detection of anti-CD3ε antibodies in biological samples.
-
公开(公告)号:US10172960B2
公开(公告)日:2019-01-08
申请号:US15465078
申请日:2017-03-21
申请人: BIONTECH AG
发明人: Steve Pascolo
IPC分类号: A61K48/00 , C12N15/11 , A61K9/16 , C07H21/02 , C07H21/04 , A61K47/64 , A61K31/7105 , A61K31/713 , A61K39/385 , A61K9/51 , A61K39/39 , A61K39/00
摘要: The present invention relates to chimeric particles comprising single stranded RNA (ssRNA), double stranded RNA (dsRNA) and at least one cationic agent, a pharmaceutical composition containing said particles and to a method of producing the same. The particles of the present invention are particularly useful as an immunostimulating medicament with a superlative pattern of immunostimulation.
-
公开(公告)号:US20180194849A1
公开(公告)日:2018-07-12
申请号:US15538419
申请日:2016-01-08
申请人: BIONTECH AG , GENMAB A/S
发明人: Ugur Sahin , Friederike Gieseke , Isil Altintas , David Satijn , Paul Parren
IPC分类号: C07K16/28
摘要: The present invention relates to binding agents binding to receptors of the TNF superfamily, in particular binding agents binding to at least two different receptors of the TNF superfamily, as well as to their use in medicine. The present invention further relates to nucleic acid molecules encoding such binding agents, to cells comprising such nucleic acid molecules and to pharmaceutical compositions and kits.
-
公开(公告)号:US20170276681A1
公开(公告)日:2017-09-28
申请号:US15518586
申请日:2015-10-19
申请人: BIONTECH AG , TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERS
发明人: Ugur Sahin , Claudia Paret , Christian Bender , Kirsten Vormbrock , Diana Barea Roldan , Stefanie Hubich , Christoph Hartmann
IPC分类号: G01N33/574 , C07K14/47 , C07K16/30 , A61K48/00 , A61K35/17 , A61K38/03 , C12Q1/68 , G01N33/50
CPC分类号: G01N33/57484 , A61K35/17 , A61K38/03 , A61K48/005 , C07K14/4747 , C07K16/30 , C12Q1/6886 , G01N33/5011 , G01N33/57407 , G01N2800/52
摘要: The present invention relates to the identification of nucleic acid and amino acid sequences that are characteristic of tumor tissues, in particular tumors of the central nervous system (CNS) such as glioma, in particular glioblastoma and which represent targets for therapy or diagnosis of tumor diseases in a subject.
-
公开(公告)号:US20170266301A1
公开(公告)日:2017-09-21
申请号:US15465078
申请日:2017-03-21
申请人: BIONTECH AG
发明人: Steve Pascolo
IPC分类号: A61K31/7105 , A61K31/713 , A61K39/385 , A61K9/16 , A61K39/00
CPC分类号: A61K47/646 , A61K9/1658 , A61K9/51 , A61K9/5169 , A61K31/7105 , A61K31/713 , A61K39/385 , A61K39/39 , A61K48/00 , A61K2039/55555 , A61K2039/55561 , A61K2039/58 , A61K2039/62
摘要: The present invention relates to chimeric particles comprising single stranded RNA (ssRNA), double stranded RNA (dsRNA) and at least one cationic agent, a pharmaceutical composition containing said particles and to a method of producing the same. The particles of the present invention are particularly useful as an immunostimulating medicament with a superlative pattern of immunostimulation.
-
公开(公告)号:US20170080068A1
公开(公告)日:2017-03-23
申请号:US15220973
申请日:2016-07-27
发明人: Ugur Sahin , Özlem Türeci , Michael Koslowski , Dirk Usener
CPC分类号: A61K39/0011 , A61K45/06 , A61K2039/5256 , A61K2039/54 , A61K2039/57 , A61K2039/572 , C07K14/4748 , C07K16/2803 , C07K16/30 , C07K2317/34 , C12Q1/6886 , C12Q2600/158 , G01N33/574
摘要: The invention relates to genetic products the expression of which is associated with cancer diseases. The invention also relates to the therapy and diagnosis of diseases in which the genetic products are expressed or aberrantly expressed, in particular cancer diseases.
-
-
-
-
-
-
-
-
-